Analyses on the mechanisms that underlie the chondroprotective properties of calcitonin

Biochemical Pharmacology

Volumn 91, Issue 3, 2014, Pages 348-358

  Greco, Karin V ^a   Nalesso, Giovanna ^a   Kaneva, Magdalena K ^a   Sherwood, Joanna ^a   Iqbal, Asif J ^a   Moradi Bidhendi, Niloufar ^a   Dell'Accio, Francesco ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDO 2 (2 METHOXYETHOXY)ACETOPHENONE; AGGRECANASE 2; CALCITONIN; CASPASE 3; CHONDROPROTECTIVE AGENT; COLLAGEN TYPE 2; COLLAGEN TYPE 2A1; COLLAGENASE 3; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; PREDNISOLONE; PROTEIN BAX; PROTEIN BCL 2; PROTEOGLYCAN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; ACAN PROTEIN, HUMAN; ADAM PROTEIN; ADAMTS5 PROTEIN, HUMAN; AGGRECAN; BIOLOGICAL MARKER; COL2A1 PROTEIN, HUMAN; MMP13 PROTEIN, HUMAN; PROTECTIVE AGENT; SOX9 PROTEIN, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CARTILAGE CELL; CHONDROPROTECTION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; NICK END LABELING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION; ARTICULAR CARTILAGE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION;

ADAM PROTEINS; AGGRECANS; APOPTOSIS; BIOLOGICAL MARKERS; CALCITONIN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLYCOSAMINOGLYCANS; HUMANS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR;

EID: 84925707221     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.07.034     Document Type: Article

References (69)

1. J.A. Buckwalter, and H.J. Mankin Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation Instr Course Lect 47 1998 487 504
2. Z. Lin, C. Willers, J. Xu, and M.H. Zheng The chondrocyte: biology and clinical application Tissue Eng 12 2006 1971 1984
3. C.W. Archer, and P. Francis-West The chondrocyte Int J Biochem Cell Biol 35 2003 401 404
4. H. Nagase, and M. Kashiwagi Aggrecanases and cartilage matrix degradation Arthritis Res Ther 5 2003 94 103
5. Y. Okada, M. Shinmei, O. Tanaka, K. Naka, A. Kimura, and I. Nakanishi Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium Lab Invest 66 1992 680 690
6. A.R. Poole, T. Kojima, T. Yasuda, F. Mwale, M. Kobayashi, and S. Laverty Composition and structure of articular cartilage: a template for tissue repair Clin Orthop Relat Res 2001 S26 S33
7. X. Houard, M.B. Goldring, and F. Berenbaum Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis Curr Rheumatol Rep 15 2013 375
8. S. Hashimoto, R.L. Ochs, S. Komiya, and M. Lotz Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis Arthritis Rheumatol 41 1998 1632 1638
9. M.J. Lopez-Armada, B. Carames, M. Lires-Dean, B. Cillero-Pastor, C. Ruiz-Romero, and F. Galdo Cytokines, tumor necrosis factor-alpha and interleukin-1beta, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes Osteoarthr Cartil 14 2006 660 669
10. M.A. Kumar, G.V. Foster, and I. Macintyre Further evidence for calcitonin. A rapid-acting hormone which lowers plasma-calcium Lancet 2 1963 480 482
11. T.J. Chambers, and A. Moore The sensitivity of isolated osteoclasts to morphological transformation by calcitonin J Clin Endo Met 57 1983 819 824
12. A. Cranney, P. Tugwell, N. Zytaruk, V. Robinson, B. Weaver, and B. Shea Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis Endocr Rev 23 2002 540 551
13. M. Seton Paget disease of bone: diagnosis and drug therapy Cleveland Clin J Med 80 2013 452 462
14. B.C. Sondergaard, H. Wulf, K. Henriksen, S. Schaller, S. Oestergaard, and P. Qvist Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes Osteoarthr Cartil 14 2006 759 768
15. B.C. Sondergaard, S.H. Madsen, T. Segovia-Silvestre, S.J. Paulsen, T. Christiansen, and C. Pedersen Investigation of the direct effects of salmon calcitonin on human osteoarthritic chondrocytes BMC Musculoskelet Disord 11 2010 62
16. B.C. Sondergaard, S. Oestergaard, C. Christiansen, L.B. Tanko, and M.A. Karsdal The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model Arthritis Rheumatol 56 2007 2674 2678
17. T. Cheng, L. Zhang, X. Fu, W. Wang, H. Xu, and H. Song The potential protective effects of calcitonin involved in coordinating chondrocyte response, extracellular matrix, and subchondral trabecular bone in experimental osteoarthritis Connect Tissue Res 54 2013 139 146
18. K.V. Greco, A.J. Iqbal, L. Rattazzi, G. Nalesso, N. Moradi-Bidhendi, and A.R. Moore High density micromass cultures of a human chondrocyte cell line: a reliable assay system to reveal the modulatory functions of pharmacological agents Biochem Pharmacol 82 2011 1919 1929
19. M.B. Goldring, J.R. Birkhead, L.F. Suen, R. Yamin, S. Mizuno, and J. Glowacki Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes J Clin Invest 94 1994 2307 2316
20. G. Nalesso, J. Sherwood, J. Bertrand, T. Pap, M. Ramachandran, and C. De Bari WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways J Cell Biol 193 2011 551 564
21. M.K. Kaneva, M.J. Kerrigan, P. Grieco, G.P. Curley, I.C. Locke, and S.J. Getting Chondroprotective and anti-inflammatory role of melanocortin peptides in TNF-alpha activated human C-20/A4 chondrocytes Br J Pharmacol 167 2012 67 79
22. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
23. M.P. Hellio, M.J. Peschard, C. Cohen, M. Richard, and E. Vignon Calcitonin inhibits phospholipase A2 and collagenase activity of human osteoarthritic chondrocytes Osteoarthr Cartil 5 1997 121 128
24. C. De Bari, F. Dell'Accio, P. Tylzanowski, and F.P. Luyten Multipotent mesenchymal stem cells from adult human synovial membrane Arthritis Rheumatol 44 2001 1928 1942
25. F. Dell'Accio, C. De Bari, and F.P. Luyten Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo Arthritis Rheumatol 44 2001 1608 1619
26. P.D. Benya, and J.D. Shaffer Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels Cell 30 1982 215 224
27. S.J. Lamp, D.M. Findlay, J.M. Moseley, and T.J. Martin Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D) J Biol Chem 256 1981 12269 12274
28. N.H. Hunt, M. Ellison, J.C. Underwood, and T.J. Martin Calcitonin-responsive adenylate cyclase in a calcitonin-producing human cancer cell line Br J Cancer 35 1977 777 784
29. O. Chabre, B.R. Conklin, H.Y. Lin, H.F. Lodish, E. Wilson, and H.E. Ives A recombinant calcitonin receptor independently stimulates 3',5'-cyclic adenosine monophosphate and Ca2+/inositol phosphate signaling pathways Mol Endocrinol 6 1992 551 556
30. M. Pondel Calcitonin and calcitonin receptors: bone and beyond Int J Exp Pathol 81 2000 405 422
31. T. Chijiwa, A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, and T. Inoue Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells J Biol Chem 265 1990 5267 5272
32. K. Deshmukh, W.G. Kline, and B.D. Sawyer Effects of calcitonin and parathyroid hormone on the metabolism of chondrocytes in culture Biochim Biophys Acta 499 1977 28 35
33. Y. Gwack, S. Feske, S. Srikanth, P.G. Hogan, and A. Rao Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes Cell Calcium 42 2007 145 156
34. E.F. Morand Effects of glucocorticoids on inflammation and arthritis Curr Opin Rheumatol 19 2007 302 307
35. H.B. Patel, M. Bombardieri, A.L. Sampaio, F. D'Acquisto, M. Gray, and P. Grieco Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis FASEB J 24 2010 4835 4843
36. P. Franchimont, C. Bassleer, Y. Henrotin, P. Gysen, and R. Bassleer Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters J Clin Endocrinol Met 69 1989 259 266
37. D.H. Manicourt, R.D. Altman, J.M. Williams, J.P. Devogelaer, A. Druetz-Van Egeren, and M.E. Lenz Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions Arthritis Rheumatol 42 1999 1159 1167
38. H. El Hajjaji, J.M. Williams, J.P. Devogelaer, M.E. Lenz, E.J. Thonar, and D.H. Manicourt Treatment with calcitonin prevents the net loss of collagen, hyaluronan and proteoglycan aggregates from cartilage in the early stages of canine experimental osteoarthritis Osteoarthr Cartil 12 2004 904 911
39. C. Behets, J.M. Williams, D. Chappard, J.P. Devogelaer, and D.H. Manicourt Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency J Bone Miner Res 19 2004 1821 1826
40. L. Khaldi, T. Karachalios, A. Galanos, and G.P. Lyritis Morphometric changes in the epiphyseal plate of the growing and young adult male rat after long-term salmon calcitonin administration Calcif Tissue Int 76 2005 426 432
41. A. Al-Kashi, T. Montero-Melendez, N. Moradi-Bidhendi, J.P. Gilligan, N. Mehta, and M. Perretti The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritis PloS One 8 2013 e54299
42. M. Kurokawa, V.P. Michelangeli, and D.M. Findlay Induction of calcitonin receptor expression by glucocorticoids in T47D human breast cancer cells J Endocrinol 130 1991 321 326
43. S. Wada, T.J. Martin, and D.M. Findlay Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells Endocrinology 136 1995 2611 2621
44. S. Wada, N. Udagawa, T. Akatsu, N. Nagata, T.J. Martin, and D.M. Findlay Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts Endocrinology 138 1997 521 529
45. R.C. Billinghurst, L. Dahlberg, M. Ionescu, A. Reiner, R. Bourne, and C. Rorabeck Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage J Clin Invest 99 1997 1534 1545
46. M. D'Angelo, Z. Yan, M. Nooreyazdan, M. Pacifici, D.S. Sarment, and P.C. Billings MMP-13 is induced during chondrocyte hypertrophy J Cell Biochem 77 2000 678 693
47. Y. Wang, F. Middleton, J.A. Horton, L. Reichel, C.E. Farnum, and T.A. Damron Microarray analysis of proliferative and hypertrophic growth plate zones identifies differentiation markers and signal pathways Bone 35 2004 1273 1293
48. P.M. van der Kraan, and W.B. van den Berg Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration Osteoarthr Cartil 20 2012 223 232
49. H. Stanton, F.M. Rogerson, C.J. East, S.B. Golub, K.E. Lawlor, and C.T. Meeker ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro Nature 434 2005 648 652
50. S.S. Glasson, R. Askew, B. Sheppard, B. Carito, T. Blanchet, and H.L. Ma Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis Nature 434 2005 644 648
51. E.R. Sampson, M.J. Hilton, Y. Tian, D. Chen, E.M. Schwarz, and R.A. Mooney Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis Sci Transl Med 3 2011 101ra93
52. D.G. Yu, H.F. Ding, Y.Q. Mao, M. Liu, B. Yu, and X. Zhao Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model Acta Pharmacol Sin 34 2013 393 402
53. J.Y. Reginster Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind randomised, placebo-controlled trial Ann Rheum Dis 73 2014 e8
54. M.A. Karsdal, A.C. Bay-Jensen, R.J. Lories, S. Abramson, T. Spector, and P. Pastoureau The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments Ann Rheum Dis 73 2014 336 348
55. M. Chakraborty, D. Chatterjee, S. Kellokumpu, H. Rasmussen, and R. Baron Cell cycle-dependent coupling of the calcitonin receptor to different G proteins Science 251 1991 1078 1082
56. F. Naro, M. Perez, S. Migliaccio, D.L. Galson, P. Orcel, and A. Teti Phospholipase D- and protein kinase C isoenzyme-dependent signal transduction pathways activated by the calcitonin receptor Endocrinology 139 1998 3241 3248
57. R. Busca, and R. Ballotti Cyclic AMP a key messenger in the regulation of skin pigmentation Pigment Cell Res 13 2000 60 69
58. N.J. de Souza, A.N. Dohadwalla, and J. Reden Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties Med Res Rev 3 1983 201 219
59. F.J. Blanco, R. Guitian, E. Vazquez-Martul, F.J. de Toro, and F. Galdo Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology Arthritis Rheumatol 41 1998 284 289
60. M.E. Nuttall, D.P. Nadeau, P.W. Fisher, F. Wang, P.M. Keller, and W.E. DeWolf Jr. Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro J Orthop Res 18 2000 356 363
61. M. Sharif, A. Whitehouse, P. Sharman, M. Perry, and M. Adams Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3 Arthritis Rheumatol 50 2004 507 515
62. D. Umlauf, S. Frank, T. Pap, and J. Bertrand Cartilage biology, pathology, and repair Cell Mol Life Sci 67 2010 4197 4211
63. M.A. Karsdal, A.C. Bay-Jensen, K. Henriksen, and C. Christiansen The pathogenesis of osteoarthritis involves bone, cartilage and synovial inflammation: may estrogen be a magic bullet Menopause Int 18 2012 139 146
64. M.A. Karsdal, B.C. Sondergaard, M. Arnold, and C. Christiansen Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis Ann N Y Acad Sci 1117 2007 181 195
65. M.A. Karsdal, E.U. Sumer, H. Wulf, S.H. Madsen, C. Christiansen, and A.J. Fosang Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation Arthritis Rheumatol 56 2007 1549 1558
66. M.A. Karsdal, L.B. Tanko, B.J. Riis, B.C. Sondergard, K. Henriksen, and R.D. Altman Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA Osteoarthr Cartil 14 2006 617 624
67. L. Mancini, N. Moradi-Bidhendi, M.L. Brandi, M. Perretti, and I. MacIntyre Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin Biochem Biophys Res Commun 279 2000 391 397
68. M.A. Karsdal, I. Byrjalsen, B.J. Riis, and C. Christiansen Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin BMC Clin Pharmacol 8 2008 12
69. N. Binkley, M. Bolognese, A. Sidorowicz-Bialynicka, T. Vally, R. Trout, and C. Miller A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial J Bone Miner Res 27 2012 1821 1829